Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Arranta Bio
Arranta Bio
Activities:
Ingredients
Research & Development
Digestion
X
LinkedIn
Trending Articles
Optimising RNA production for faster and cheaper pharmaceutical manufacturing
RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool
The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Drug Delivery
Arranta Bio signs contract for continuous mRNA manufacturing tech
The contract with the CDMO is part of the FDA’s initiative to have a fully integrated, continuous manufacturing production line for mRNA vaccines
Ingredients
Arranta Bio completes sale of Florida site
The company has completed the sale of its Floria site and progress on $150M investment plan to expand development and commercial manufacturing services
Ingredients
New microbiome specialist raises $82m and partners with Thermo Fisher
Arranta Bio will have access to Thermo Fisher’s full suite of products and services and will provide materials to Thermo Fisher for use in gene therapy production
Subscribe now